03:23 PM EDT, 07/09/2026 (MT Newswires) -- Healthcare stocks declined late Thursday afternoon, with the NYSE Healthcare Index shedding 0.5% and the State Street Health Care Select Sector SPDR ETF (XLV) down 0.4%.

The iShares Biotechnology ETF (IBB) increased 0.3%.

In corporate news, Fate Therapeutics ( FATE ) shares rose nearly 6% after the US Food and Drug Administration approved the company's investigational new drug application for FT839, a product candidate to treat autoimmune diseases.